These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30736835)

  • 1. Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series.
    Waddington-Cruz M; Schmidt H; Botteman MF; Carter JA; Stewart M; Hopps M; Fallet S; Amass L
    Orphanet J Rare Dis; 2019 Feb; 14(1):34. PubMed ID: 30736835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
    Adams D; Ando Y; Beirão JM; Coelho T; Gertz MA; Gillmore JD; Hawkins PN; Lousada I; Suhr OB; Merlini G
    J Neurol; 2021 Jun; 268(6):2109-2122. PubMed ID: 31907599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: Characterization of Brazilian subjects from the THAOS registry.
    Pinto MV; Pinto LF; Dias M; Rosa RS; Mundayat R; Pedrosa RC; Waddington-Cruz M
    J Neurol Sci; 2019 Aug; 403():1-6. PubMed ID: 31163298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases of late onset familial amyloid polyneuropathy with a Glu61Lys transthyretin variant.
    Nakano Y; Tadokoro K; Ohta Y; Sato K; Takemoto M; Hishikawa N; Yamashita T; Yamashita T; Ando Y; Abe K
    J Neurol Sci; 2018 Jul; 390():22-25. PubMed ID: 29801893
    [No Abstract]   [Full Text] [Related]  

  • 5. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan.
    Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y
    Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of two induced pluripotent stem cell lines from hereditary amyloidosis patients with polyneuropathy carrying heterozygous transthyretin (TTR) mutation.
    Melesio J; Bonilauri B; Li A; Pang PD; Liao R; Witteles RM; Wu JC; Sallam K
    Stem Cell Res; 2024 Feb; 74():103265. PubMed ID: 38100909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tafamidis: A Review in Transthyretin Amyloidosis with Polyneuropathy.
    Lamb YN; Deeks ED
    Drugs; 2019 Jun; 79(8):863-874. PubMed ID: 31098895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.
    Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y
    Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.
    Yamashita T; Ueda M; Misumi Y; Masuda T; Nomura T; Tasaki M; Takamatsu K; Sasada K; Obayashi K; Matsui H; Ando Y
    J Neurol; 2018 Jan; 265(1):134-140. PubMed ID: 29177547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electro-clinical presentation of hereditary transthyretin related amyloidosis when presenting as a polyneuropathy of unknown origin in northern France.
    Davion JB; Bocquillon P; Cassim F; Frezel N; Lacour A; Dhaenens CM; Maurage CA; Gibier JB; Hachulla E; Nguyen The Tich S; Defebvre L; Merle PE; Tard C
    Rev Neurol (Paris); 2021 Nov; 177(9):1160-1167. PubMed ID: 34253345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort.
    Pasutharnchat N; Taychargumpoo C; Vorasettakarnkij Y; Amornvit J
    BMC Neurol; 2021 May; 21(1):206. PubMed ID: 34022837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic and genetic features of early- and late-onset FAP type I (FAP ATTR Val30Met) in Japan.
    Sobue G; Koike H; Misu K; Hattori N; Yamamoto M; Ikeda S; Ando Y; Nakazato M; Inukai A
    Amyloid; 2003 Aug; 10 Suppl 1():32-8. PubMed ID: 14640040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy.
    Hattori T; Takei Y; Koyama J; Nakazato M; Ikeda S
    Amyloid; 2003 Dec; 10(4):229-39. PubMed ID: 14986482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups.
    Rintell D; Heath D; Braga Mendendez F; Cross E; Cross T; Knobel V; Gagnon B; Turtle C; Cohen A; Kalmykov E; Fox J
    Orphanet J Rare Dis; 2021 Feb; 16(1):70. PubMed ID: 33557882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases.
    Beirão JM; Malheiro J; Lemos C; Beirão I; Costa P; Torres P
    Amyloid; 2015; 22(2):117-22. PubMed ID: 26096568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy.
    Tojo K; Tsuchiya-Suzuki A; Sekijima Y; Morita H; Sumita N; Ikeda S
    Amyloid; 2010 Mar; 17(1):32-5. PubMed ID: 20132088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline disease characteristics in Brazilian patients enrolled in Transthyretin Amyloidosis Outcome Survey (THAOS).
    Cruz MW; Pinto MV; Pinto LF; Gervais R; Dias M; Perez C; Mundayat R; Ong ML; Pedrosa RC; Foguel D
    Arq Neuropsiquiatr; 2019 Feb; 77(2):96-100. PubMed ID: 30810593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history and survival rate of familial amyloidosis with polyneuropathy: A nationwide databank.
    Tseng WH; Huang HW; Li CC; Chang CS; Chan WP; Lin KP; Wu CH
    Ann Clin Transl Neurol; 2023 May; 10(5):779-786. PubMed ID: 37042639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis.
    Lin X; Yarlas A; Vera-Llonch M; Baranwal N; Biber J; Brown D; Vogt B; Karam C
    BMC Neurol; 2021 Feb; 21(1):70. PubMed ID: 33579211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathological features of familial amyloid polyneuropathy].
    Koike H; Sobue G
    Rinsho Shinkeigaku; 2011 Nov; 51(11):1134-7. PubMed ID: 22277509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.